Authors: RACE E GILBERT SM SHELDON JG ROSE JSL MOFFATT AR SITBON G DISSANAYEKE SR CAMMACK N DUNCAN IB

Citation: E. Race et al., CORRELATION OF RESPONSE TO TREATMENT AND HIV GENOTYPIC CHANGES DURINGPHASE-III TRIALS WITH SAQUINAVIR AND REVERSE-TRANSCRIPTASE INHIBITOR COMBINATION THERAPY, AIDS, 12(12), 1998, pp. 1465-1474

Authors: SITBON G HURTIG M PALOTIE A LONNGREN J SYVANEN AC

Citation: G. Sitbon et al., A COLORIMETRIC MINISEQUENCING ASSAY FOR THE MUTATION IN CODON-506 OF THE COAGULATION-FACTOR-V GENE, Thrombosis and haemostasis, 77(4), 1997, pp. 701-703

Authors: SITBON G ALBERT J APERIA K HURTIG M JOHANSSON C MOBERG C HOLMBERG V SANDSTROM E

Citation: G. Sitbon et al., PATTERN OF DRUG-RESISTANCE MUTATIONS DURING COMBINATION THERAPY WITH AZT AND ZALCITABINE DIDANOSINE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 30-30

Authors: BEENTIKTAK AMM JOLY V SITBON G COLLIN G DEVOS M DEGRAAF L DEHAAN C BOUCHER C BRUMVEZINET F

Citation: Amm. Beentiktak et al., COMBINATION THERAPY WITH DELAVIRDINE MESYLATE AND AZT - VIROLOGY DATAFROM A EUROPEAN PHASE-II TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 48-48